Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196952 | SCV001367586 | uncertain significance | Naxos disease | 2020-03-05 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,PM5. |
Labcorp Genetics |
RCV001343964 | SCV001537990 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2023-05-31 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 930937). This variant has not been reported in the literature in individuals affected with JUP-related conditions. This variant is present in population databases (rs782392706, gnomAD 0.005%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 136 of the JUP protein (p.Asp136Asn). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Dept of Medical Biology, |
RCV003318396 | SCV004022099 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: PM2, PP3 |